These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 36563966)

  • 1. Changed firing activity of nigra dopaminergic neurons in Parkinson's disease.
    Chen XY; Liu C; Xue Y; Chen L
    Neurochem Int; 2023 Jan; 162():105465. PubMed ID: 36563966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Several neuropeptides involved in parkinsonian neuroprotection modulate the firing properties of nigral dopaminergic neurons.
    Chen L; Liu C; Xue Y; Chen XY
    Neuropeptides; 2023 Jun; 99():102337. PubMed ID: 37087783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide apelin presented in the dopaminergic neurons modulates the neuronal excitability in the substantia nigra pars compacta.
    Liu C; Kang NW; Wang Y; Xue Y; Chen XY; Chen L
    Neuropharmacology; 2022 Nov; 219():109235. PubMed ID: 36041497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
    Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
    Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-Expression of Nogo-A in Dopaminergic Neurons of the Human Substantia Nigra Pars Compacta Is Reduced in Parkinson's Disease.
    Eyer GC; Di Santo S; Hewer E; Andereggen L; Seiler S; Widmer HR
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GLP-1 modulated the firing activity of nigral dopaminergic neurons in both normal and parkinsonian mice.
    Liu C; Liu WH; Yang W; Chen L; Xue Y; Chen XY
    Neuropharmacology; 2024 Jul; 252():109946. PubMed ID: 38599494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Representation of spontaneous movement by dopaminergic neurons is cell-type selective and disrupted in parkinsonism.
    Dodson PD; Dreyer JK; Jennings KA; Syed EC; Wade-Martins R; Cragg SJ; Bolam JP; Magill PJ
    Proc Natl Acad Sci U S A; 2016 Apr; 113(15):E2180-8. PubMed ID: 27001837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age and Parkinson's disease-related neuronal death in the substantia nigra pars compacta.
    Eriksen N; Stark AK; Pakkenberg B
    J Neural Transm Suppl; 2009; (73):203-13. PubMed ID: 20411779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiological characterization of substantia nigra dopaminergic neurons in partially lesioned rats: effects of subthalamotomy and levodopa treatment.
    Bilbao G; Ruiz-Ortega JA; Miguens N; Ulibarri I; Linazasoro G; Gómez-Urquijo S; Garibi J; Ugedo L
    Brain Res; 2006 Apr; 1084(1):175-84. PubMed ID: 16574080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons.
    Dragicevic E; Poetschke C; Duda J; Schlaudraff F; Lammel S; Schiemann J; Fauler M; Hetzel A; Watanabe M; Lujan R; Malenka RC; Striessnig J; Liss B
    Brain; 2014 Aug; 137(Pt 8):2287-302. PubMed ID: 24934288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GABAergic control of rat substantia nigra dopaminergic neurons: role of globus pallidus and substantia nigra pars reticulata.
    Celada P; Paladini CA; Tepper JM
    Neuroscience; 1999 Mar; 89(3):813-25. PubMed ID: 10199615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopaminergic Neurons Exhibit an Age-Dependent Decline in Electrophysiological Parameters in the MitoPark Mouse Model of Parkinson's Disease.
    Branch SY; Chen C; Sharma R; Lechleiter JD; Li S; Beckstead MJ
    J Neurosci; 2016 Apr; 36(14):4026-37. PubMed ID: 27053209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological changes in dendrites of substantia nigra neurons in Parkinson's disease: a Golgi study.
    Patt S; Gertz HJ; Gerhard L; Cervós-Navarro J
    Histol Histopathol; 1991 Jul; 6(3):373-80. PubMed ID: 1725760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
    Huang KX; Bergstrom DA; Ruskin DN; Walters JR
    Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
    Hill WD; Arai M; Cohen JA; Trojanowski JQ
    J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine-dependent early synaptic and motor dysfunctions induced by α-synuclein in the nigrostriatal circuit.
    Tozzi A; Sciaccaluga M; Loffredo V; Megaro A; Ledonne A; Cardinale A; Federici M; Bellingacci L; Paciotti S; Ferrari E; La Rocca A; Martini A; Mercuri NB; Gardoni F; Picconi B; Ghiglieri V; De Leonibus E; Calabresi P
    Brain; 2021 Dec; 144(11):3477-3491. PubMed ID: 34297092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subtypes of substantia nigra dopaminergic neurons revealed by apamin: autoradiographic and electrophysiological studies.
    Gu X; Blatz AL; German DC
    Brain Res Bull; 1992 Mar; 28(3):435-40. PubMed ID: 1350500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal vulnerability in Parkinson's disease.
    Double KL
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S52-4. PubMed ID: 22166454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea.
    Waters CM; Peck R; Rossor M; Reynolds GP; Hunt SP
    Neuroscience; 1988 May; 25(2):419-38. PubMed ID: 2456487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.